Kevin Sheng‐Kai

1.8k total citations · 1 hit paper
74 papers, 638 citations indexed

About

Kevin Sheng‐Kai is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kevin Sheng‐Kai has authored 74 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kevin Sheng‐Kai's work include Diabetes Treatment and Management (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Oral microbiology and periodontitis research (5 papers). Kevin Sheng‐Kai is often cited by papers focused on Diabetes Treatment and Management (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Oral microbiology and periodontitis research (5 papers). Kevin Sheng‐Kai collaborates with scholars based in United States, Taiwan and United Kingdom. Kevin Sheng‐Kai's co-authors include James Cheng‐Chung Wei, Li‐Tzu Wang, Meng‐Che Wu, Yu‐Hsun Wang, Cho‐Han Chiang, Jing‐Yang Huang, Thomas E. Van Dyke, Cho‐Hung Chiang, Jung‐Nien Lai and Chien‐Chang Lee and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Kevin Sheng‐Kai

67 papers receiving 635 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Increased Risk of Aspiration Pneumonia Associated With Endoscopic Procedures Among Patients With Glucagon-like Peptide 1 Receptor Agonist Use

2024 57 citations Yee Hui Yeo, Srinivas Gaddam et al. Gastroenterology profile →

Peers

Kevin Sheng‐Kai

SURGE

EDM

PRM

PHYSI

İsmail Yıldız Türkiye

C. Tolédano France

María Pilar Cruz-Domínguez Mexico

Osama Moussa United Kingdom

Sargam Kapoor United States

Barbara E. Ostrov United States

Soamarat Vilaiyuk Thailand

M. Zulf Mughal United Kingdom

Ekaterini Siomou Greece

Yasser Wali Oman

İsmail Yıldız Türkiye

Kevin Sheng‐Kai

116 ×1.0

SURGE

61 ×0.6

EDM

75 ×0.8

PRM

67 ×0.8

PHYSI

74 ×0.9

Citations per year, relative to Kevin Sheng‐Kai Kevin Sheng‐Kai (= 1×) peers İsmail Yıldız

Countries citing papers authored by Kevin Sheng‐Kai

Since Specialization

Citations

This map shows the geographic impact of Kevin Sheng‐Kai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Sheng‐Kai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Sheng‐Kai more than expected).

Fields of papers citing papers by Kevin Sheng‐Kai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Sheng‐Kai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Sheng‐Kai. The network helps show where Kevin Sheng‐Kai may publish in the future.

Co-authorship network of co-authors of Kevin Sheng‐Kai

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Sheng‐Kai. A scholar is included among the top collaborators of Kevin Sheng‐Kai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Sheng‐Kai. Kevin Sheng‐Kai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Braun, Natalie, et al.. (2025). The Burden of Skin and Subcutaneous Diseases in North Africa and the Middle East (NAME) From 1990 to 2021. International Journal of Dermatology. 64(12). 2274–2282.

Ng, Wee Han, Yee Hui Yeo, Hyun‐Seok Kim, et al.. (2025). Renin-angiotensin-aldosterone system inhibitor use improves clinical outcomes in patients with metabolic dysfunction–associated steatotic liver diseases: Target trial emulation using real-world data. Hepatology. 83(2). 333–343. 5 indexed citations

Ananthakrishnan, Ashwin N., et al.. (2025). Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study. Pediatric Drugs. 27(6). 761–770.

Hawryluk, Elena B., et al.. (2025). Adjunctive therapy use following Janus kinase inhibitors versus dupilumab in atopic dermatitis. The Journal of Allergy and Clinical Immunology In Practice. 13(11). 3143–3145.e1.

Ahn, Joseph, Wee Han Ng, Yee Hui Yeo, et al.. (2025). Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation. Hepatology. 83(2). 249–260. 3 indexed citations

Braun, Natalie, et al.. (2025). Glucagon-like peptide-1 receptor agonists mitigate the risk of major adverse cardiovascular events in patients with atopic dermatitis and type 2 diabetes. Journal of the American Academy of Dermatology. 93(6). 1591–1594.

Kuang, Chaoyuan, et al.. (2024). Safety and efficacy of liposomal irinotecan as the second-line treatment for advanced pancreatic cancer: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 201. 104386–104386. 5 indexed citations

Sheng‐Kai, Kevin, et al.. (2024). New-onset keratitis associated with epidermal growth factor receptor-based targeted therapies in Han Chinese patients with lung cancer: A multi-center cohort study. The Ocular Surface. 33. 23–30. 4 indexed citations

Huang, Jing‐Yang, et al.. (2024). Maternal human papillomavirus infection and the risk of congenital malformations: A nationwide population‐based cohort study. Journal of Medical Virology. 96(4). e29549–e29549.

10.

Sheng‐Kai, Kevin, et al.. (2024). Efficacy and Safety of Sodium–Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Cardiovascular, Renal Events, and Safety Outcomes in Patients With Systemic Lupus Erythematosus and Comorbid Type 2 Diabetes: A Population‐Based Target Trial Emulation. Arthritis & Rheumatology. 77(4). 414–422. 5 indexed citations

11.

Sheng‐Kai, Kevin, et al.. (2024). Effects of sodium-glucose cotransporter-2 inhibitors on inflammatory skin diseases in patients with type 2 diabetes. Journal of the American Academy of Dermatology. 91(5). 934–936. 5 indexed citations

12.

Yeo, Yee Hui, Srinivas Gaddam, Wee Han Ng, et al.. (2024). Increased Risk of Aspiration Pneumonia Associated With Endoscopic Procedures Among Patients With Glucagon-like Peptide 1 Receptor Agonist Use. Gastroenterology. 167(2). 402–404.e3. 57 indexed citations breakdown →

13.

Gaffin, Jonathan M., Elena B. Hawryluk, Lisa M. Bartnikas, et al.. (2024). Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population‐based cohort study. Allergy. 79(10). 2748–2758. 10 indexed citations

14.

Sheng‐Kai, Kevin, et al.. (2024). Tooth Loss and Chronic Pain: A Population-based Analysis of the National Health and Nutrition Examination Survey. Journal of Pain. 25(9). 104529–104529. 2 indexed citations

15.

Wu, Meng‐Che, et al.. (2023). Association of early childhood constipation with the risk of autism spectrum disorder in Taiwan: Real-world evidence from a nationwide population-based cohort study. Frontiers in Psychiatry. 14. 1116239–1116239. 5 indexed citations

16.

Chiang, Cho‐Han, et al.. (2022). The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma. Pancreas. 51(8). e107–e109. 2 indexed citations

17.

Chiang, Cho‐Han, Cho‐Hung Chiang, Kevin Sheng‐Kai, et al.. (2022). Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer. Heart. 109(6). 470–477. 40 indexed citations

18.

Chiang, Cho‐Han, Cho‐Hung Chiang, Kevin Sheng‐Kai, et al.. (2022). The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations. Japanese Journal of Clinical Oncology. 52(12). 1389–1398. 21 indexed citations

19.

Sheng‐Kai, Kevin, et al.. (2021). Onset of oral lichen planus following dental treatments: A nested case–control study. Oral Diseases. 29(3). 1269–1281. 13 indexed citations

20.

Sheng‐Kai, Kevin, et al.. (2021). Fibromyalgia and periodontitis: Bidirectional associations in population‐based 15‐year retrospective cohorts. Journal of Periodontology. 93(6). 877–887. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact